![Mogens Vang Rasmussen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mogens Vang Rasmussen
Corporate Officer/Principal bei
Vesicon SAS
Profil
Mogens Vang Rasmussen is currently a Partner at Vesicon SAS. Previously, he held positions such as Chairman at Pila Pharma AB, Independent Director at Hybrigenics SA, Vice President & Senior Economist at TDC Holding A, Manager at Novo Nordisk A, and Chief Financial Officer at MediCult A. From 2009 to 2010, he was the CFO, COO, EVP & Head-Information Technology at Zealand Pharma.
A. He also worked as a Partner at Valneva SE.
Mr. Rasmussen obtained his undergraduate degree from the University of Copenhagen.
Aktive Positionen von Mogens Vang Rasmussen
| Unternehmen | Position | Beginn |
|---|---|---|
Vesicon SAS
 Vesicon SAS Medical SpecialtiesHealth Technology Manufactures ultrasonic therapy devices | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mogens Vang Rasmussen
| Unternehmen | Position | Ende |
|---|---|---|
| ATON | Direktor/Vorstandsmitglied | 14.10.2019 |
| ZEALAND PHARMA A/S | Finanzdirektor/CFO | 01.01.2010 |
| TDC A/S | Corporate Officer/Principal | - |
| PILA PHARMA AB | Vorsitzender | - |
| VALNEVA SE | Corporate Officer/Principal | - |
Ausbildung von Mogens Vang Rasmussen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
TDC Holding A/S
 TDC Holding A/S Wireless TelecommunicationsCommunications Provides mobile, fiber-net, TV, broadband, network and telephony services for private customers & businesses | Communications |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
MediCult A/S
 MediCult A/S BiotechnologyHealth Technology Develops, manufactures, and markets specialized culture media for Assisted Reproduction Technologies | Health Technology |
Hybrigenics SA
 Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Pila Pharma AB
 Pila Pharma AB BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company which develops oral anti-diabetic agents | Health Technology |
Vesicon SAS
Vesicon SAS Medical SpecialtiesHealth Technology Manufactures ultrasonic therapy devices | Health Technology |
